Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: A randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN Study)
2011

Early Detection and Intervention for Kidney Injury from Contrast Media

Sample size: 1200 publication Evidence: moderate

Author Information

Author(s): Gernot Schilcher, Werner Ribitsch, Ronald Otto, Rupert H Portugaller, Franz Quehenberger, Martini Truschnig-Wilders, Robert Zweiker, Philipp Stiegler, Marianne Brodmann, Klemens Weinhandl, Joerg H Horina

Primary Institution: Medical University of Graz, Austria

Hypothesis

Earlier detection of CIN by the novel urinary NGAL test method enables amelioration of renal injury by the introduction of rapid and intensified post-procedural (angiography) volume expansion.

Conclusion

The study aims to evaluate the effectiveness of NGAL as an early predictor of contrast media induced nephropathy and the benefits of early intravenous hydration.

Supporting Evidence

  • NGAL is a new biomarker that can help detect kidney injury earlier.
  • Patients with chronic kidney disease may have different NGAL levels, complicating diagnosis.
  • Intravenous hydration is currently the only proven method to prevent contrast-induced nephropathy.

Takeaway

This study is trying to find out if a new test can help doctors catch kidney problems early and if giving patients extra fluids after a procedure can help their kidneys stay healthy.

Methodology

The study is a single center, open label, randomized controlled trial involving patients undergoing intra-arterial angiography with standardized intravenous hydration before the procedure.

Potential Biases

Potential bias in randomization due to the nature of the intervention and the inability to blind participants and investigators.

Limitations

The study may face challenges in defining a reliable cut-off for NGAL in patients with chronic kidney disease and the variability in hydration regimens used in previous studies.

Participant Demographics

Patients older than 18 years with clinically stable chronic kidney disease of stage 2 or more.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2369-12-39

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication